Copy Number Variations, Inflammatory Cytokines and the Risk of Dementia

Dementia Clinical Trial

Official title:

Copy Number Variations, Expression of Inflammatory Cytokines and the Risk of Dementia - A Two-stage Genome-wide Association Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00878280
• Other study ID #: 200712102R-1
• Status: Recruiting
• Phase: N/A
• First received: August 31, 2008
• Last updated: April 21, 2011
• Start date: August 2008
• Est. completion date: July 2011

Study information

• Verified date: April 2011
• Source: National Taiwan University Hospital
• Contact: Yen-Ching Chen, ScD
• Phone: 886-2-33668019
• Email: chenkaren[@]yahoo.com
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

Assess the association of copy number variation (CNV) and inflammatory cytokine with the risk of dementia.

Description:

This is a hospital-based case-control study. We plan to assess the association of CNV and inflammatory cytokine with the risk of dementia. Hopefully to find some genetic biomarkers to identify the risk of dementia at an early stage.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 700
• Est. completion date: July 2011
• Est. primary completion date: July 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 50 Years and older

Eligibility

Inclusion Criteria:

• hospital recruited dementia patients and controls

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Dementia

Locations

Country	Name	City	State
Taiwan	National Taiwan University Hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Dementia		Aug 2008-July 2011	No